 Alpna Tyagi
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 4 | 2023 | 55 | 2.300 |
Why?
| | Metabolic Syndrome | 4 | 2023 | 338 | 2.280 |
Why?
| | Grape Seed Extract | 6 | 2019 | 44 | 1.730 |
Why?
| | Antineoplastic Agents, Phytogenic | 7 | 2019 | 185 | 1.300 |
Why?
| | Alzheimer Disease | 4 | 2023 | 516 | 1.270 |
Why?
| | Silymarin | 13 | 2011 | 198 | 1.090 |
Why?
| | Anthocyanins | 2 | 2019 | 31 | 1.040 |
Why?
| | Apoptosis | 15 | 2019 | 2435 | 0.950 |
Why?
| | Plaque, Amyloid | 2 | 2022 | 15 | 0.900 |
Why?
| | Amyloid | 3 | 2023 | 83 | 0.890 |
Why?
| | Insulysin | 1 | 2022 | 1 | 0.830 |
Why?
| | Stilbenes | 4 | 2013 | 36 | 0.740 |
Why?
| | Anticarcinogenic Agents | 4 | 2013 | 77 | 0.740 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 110 | 0.720 |
Why?
| | STAT3 Transcription Factor | 6 | 2013 | 190 | 0.700 |
Why?
| | Prostatic Neoplasms | 5 | 2019 | 1011 | 0.680 |
Why?
| | Biflavonoids | 1 | 2019 | 9 | 0.630 |
Why?
| | Proanthocyanidins | 1 | 2019 | 10 | 0.630 |
Why?
| | Catechin | 1 | 2019 | 26 | 0.620 |
Why?
| | Urinary Bladder Neoplasms | 4 | 2013 | 226 | 0.590 |
Why?
| | Mitochondria | 3 | 2023 | 848 | 0.570 |
Why?
| | Nitric Oxide Synthase Type II | 4 | 2011 | 167 | 0.560 |
Why?
| | Inflammasomes | 1 | 2018 | 128 | 0.550 |
Why?
| | NF-kappa B | 5 | 2013 | 649 | 0.530 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 386 | 0.470 |
Why?
| | Carcinogens | 3 | 2013 | 110 | 0.400 |
Why?
| | Receptors, Androgen | 1 | 2013 | 143 | 0.400 |
Why?
| | Lung Neoplasms | 5 | 2011 | 2328 | 0.390 |
Why?
| | Cell Line, Tumor | 11 | 2013 | 3184 | 0.380 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 172 | 0.370 |
Why?
| | Down-Regulation | 6 | 2022 | 631 | 0.370 |
Why?
| | Smad4 Protein | 1 | 2011 | 37 | 0.370 |
Why?
| | Brain | 3 | 2023 | 2620 | 0.360 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 577 | 0.360 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 114 | 0.340 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2013 | 620 | 0.330 |
Why?
| | Mice | 14 | 2023 | 16602 | 0.320 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 147 | 0.310 |
Why?
| | DNA Damage | 1 | 2011 | 364 | 0.310 |
Why?
| | Neovascularization, Pathologic | 3 | 2010 | 290 | 0.310 |
Why?
| | Cell Proliferation | 9 | 2019 | 2344 | 0.300 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 2007 | 6 | 0.290 |
Why?
| | Interferon-gamma | 1 | 2011 | 759 | 0.290 |
Why?
| | Transforming Growth Factor alpha | 1 | 2008 | 55 | 0.290 |
Why?
| | Autocrine Communication | 1 | 2008 | 43 | 0.290 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2008 | 38 | 0.290 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2013 | 508 | 0.290 |
Why?
| | Cell Survival | 3 | 2019 | 1077 | 0.280 |
Why?
| | Interleukin-1beta | 2 | 2020 | 373 | 0.280 |
Why?
| | Angiogenesis Inhibitors | 1 | 2009 | 215 | 0.270 |
Why?
| | Caspase 2 | 1 | 2006 | 14 | 0.260 |
Why?
| | cdc25 Phosphatases | 2 | 2006 | 14 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1185 | 0.260 |
Why?
| | CDC2 Protein Kinase | 2 | 2006 | 31 | 0.260 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 533 | 0.260 |
Why?
| | S Phase | 1 | 2005 | 73 | 0.240 |
Why?
| | Animals | 15 | 2023 | 34479 | 0.230 |
Why?
| | Tyrosine | 1 | 2005 | 217 | 0.230 |
Why?
| | Cell Cycle | 4 | 2011 | 581 | 0.230 |
Why?
| | ErbB Receptors | 1 | 2008 | 601 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 179 | 0.220 |
Why?
| | Signal Transduction | 6 | 2011 | 4826 | 0.210 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 930 | 0.210 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2022 | 26 | 0.210 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2011 | 1351 | 0.200 |
Why?
| | Phosphorylation | 5 | 2013 | 1681 | 0.200 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2022 | 81 | 0.190 |
Why?
| | Adenocarcinoma | 1 | 2009 | 888 | 0.190 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 70 | 0.190 |
Why?
| | Cell Movement | 2 | 2019 | 936 | 0.180 |
Why?
| | Caspase 9 | 2 | 2013 | 54 | 0.170 |
Why?
| | MAP Kinase Signaling System | 2 | 2013 | 302 | 0.170 |
Why?
| | Amyloidosis | 1 | 2020 | 39 | 0.170 |
Why?
| | Carcinoma | 3 | 2011 | 214 | 0.170 |
Why?
| | Male | 16 | 2020 | 62858 | 0.170 |
Why?
| | Cytochromes c | 2 | 2013 | 61 | 0.170 |
Why?
| | Antineoplastic Agents | 5 | 2013 | 2051 | 0.160 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 242 | 0.160 |
Why?
| | Ovarian Neoplasms | 1 | 2005 | 488 | 0.160 |
Why?
| | Immunoblotting | 2 | 2011 | 300 | 0.160 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3937 | 0.160 |
Why?
| | Jagged-1 Protein | 1 | 2019 | 22 | 0.160 |
Why?
| | Caspase 3 | 2 | 2013 | 228 | 0.160 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 50 | 0.150 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1664 | 0.150 |
Why?
| | Receptor, Notch1 | 1 | 2019 | 61 | 0.150 |
Why?
| | Mice, Nude | 5 | 2011 | 682 | 0.150 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 84 | 0.150 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 73 | 0.150 |
Why?
| | Caspase 1 | 1 | 2018 | 142 | 0.150 |
Why?
| | Diet, Western | 1 | 2018 | 79 | 0.150 |
Why?
| | Microglia | 1 | 2020 | 228 | 0.150 |
Why?
| | Prostate | 1 | 2019 | 178 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 5 | 2011 | 814 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 153 | 0.140 |
Why?
| | Cell Cycle Proteins | 4 | 2010 | 577 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2013 | 1176 | 0.130 |
Why?
| | In Situ Nick-End Labeling | 3 | 2013 | 120 | 0.130 |
Why?
| | Fatty Acids | 1 | 2018 | 415 | 0.120 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 809 | 0.120 |
Why?
| | Humans | 18 | 2023 | 128418 | 0.110 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2018 | 2755 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 23 | 0.110 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 15 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1045 | 0.100 |
Why?
| | Vitis | 1 | 2013 | 41 | 0.100 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2013 | 87 | 0.100 |
Why?
| | Seeds | 1 | 2013 | 84 | 0.100 |
Why?
| | Colorectal Neoplasms | 2 | 2010 | 746 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 190 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1164 | 0.090 |
Why?
| | Comet Assay | 1 | 2011 | 17 | 0.090 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2011 | 55 | 0.090 |
Why?
| | Cyclin D1 | 2 | 2008 | 63 | 0.090 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2011 | 71 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 112 | 0.090 |
Why?
| | BRCA1 Protein | 1 | 2011 | 65 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 2 | 2013 | 190 | 0.090 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 87 | 0.080 |
Why?
| | Antioxidants | 2 | 2010 | 538 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 815 | 0.080 |
Why?
| | Checkpoint Kinase 2 | 2 | 2006 | 23 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 893 | 0.080 |
Why?
| | Azoxymethane | 1 | 2008 | 18 | 0.080 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2006 | 64 | 0.080 |
Why?
| | beta Catenin | 1 | 2010 | 219 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 15 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2008 | 18 | 0.070 |
Why?
| | Microvessels | 1 | 2009 | 79 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 825 | 0.070 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 107 | 0.070 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2008 | 60 | 0.070 |
Why?
| | Blotting, Western | 4 | 2011 | 1164 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2008 | 161 | 0.070 |
Why?
| | Gallic Acid | 1 | 2006 | 13 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2008 | 1936 | 0.070 |
Why?
| | Toluene | 1 | 2006 | 11 | 0.070 |
Why?
| | Androgens | 1 | 2008 | 173 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2006 | 313 | 0.070 |
Why?
| | Benzothiazoles | 1 | 2006 | 32 | 0.070 |
Why?
| | Histones | 1 | 2011 | 586 | 0.060 |
Why?
| | Ataxia Telangiectasia | 1 | 2005 | 17 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2005 | 22 | 0.060 |
Why?
| | Checkpoint Kinase 1 | 1 | 2005 | 31 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2011 | 1032 | 0.060 |
Why?
| | Neurofibrillary Tangles | 1 | 2023 | 13 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4001 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2008 | 575 | 0.050 |
Why?
| | Protein Kinases | 1 | 2005 | 309 | 0.050 |
Why?
| | Multigene Family | 1 | 2023 | 198 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2011 | 799 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1421 | 0.050 |
Why?
| | Macrophages | 1 | 2009 | 1460 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 211 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 1983 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2008 | 2675 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 3689 | 0.040 |
Why?
| | Cell Death | 2 | 2013 | 348 | 0.040 |
Why?
| | Janus Kinase 1 | 2 | 2011 | 24 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1691 | 0.040 |
Why?
| | Female | 3 | 2020 | 68154 | 0.040 |
Why?
| | Time Factors | 1 | 2008 | 6482 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 71 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2013 | 95 | 0.030 |
Why?
| | Superoxides | 1 | 2013 | 196 | 0.030 |
Why?
| | Cytoplasm | 1 | 2013 | 257 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2013 | 209 | 0.020 |
Why?
| | HT29 Cells | 1 | 2011 | 36 | 0.020 |
Why?
| | Nestin | 1 | 2010 | 19 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2010 | 57 | 0.020 |
Why?
| | Urethane | 1 | 2010 | 41 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 265 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 81 | 0.020 |
Why?
| | X-Ray Microtomography | 1 | 2010 | 84 | 0.020 |
Why?
| | Genes, APC | 1 | 2010 | 13 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2010 | 78 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2010 | 44 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 510 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 283 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 371 | 0.020 |
Why?
| | Wnt Proteins | 1 | 2010 | 126 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 370 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 308 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 50 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2010 | 371 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2008 | 251 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 168 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1020 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2008 | 45 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1001 | 0.020 |
Why?
| | Janus Kinase 2 | 1 | 2007 | 32 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2135 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 567 | 0.020 |
Why?
| | Cyclins | 1 | 2006 | 85 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2006 | 130 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 242 | 0.020 |
Why?
| | Administration, Oral | 1 | 2008 | 754 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2008 | 399 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5272 | 0.010 |
Why?
| | Rats | 1 | 2008 | 5165 | 0.010 |
Why?
| | Lung | 1 | 2010 | 3743 | 0.010 |
Why?
|
|
Tyagi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|